From 2e8da9a4a2ae17f74b50611f78083eb5d6276cbc Mon Sep 17 00:00:00 2001
From: gina-kuffel <gkuffel22@gmail.com>
Date: Fri, 8 May 2026 11:21:50 -0500
Subject: [PATCH] small update for ICDC-3983

---
 model-desc/icdc-model-props.yml | 13 ++++++++++++-
 model-desc/icdc-model.yml       |  1 +
 2 files changed, 13 insertions(+), 1 deletion(-)

diff --git a/model-desc/icdc-model-props.yml b/model-desc/icdc-model-props.yml
index e833003..b8ce229 100644
--- a/model-desc/icdc-model-props.yml
+++ b/model-desc/icdc-model-props.yml
@@ -2033,6 +2033,17 @@ PropDefinitions:
       - Pending
       - Under Embargo
     Req: 'Yes'
+  study_accession:
+    Desc: dbGaP study accession number 
+    Req: false 
+    Type:
+      pattern: ^phs[0-9]+$
+    Term:
+    - Origin: caDSR
+      Original Source: DSS CDE
+      Code: '11524544'
+      Value: Research Activity dbGaP Accession Number Identifier
+      Version: '1.00'
   # study_arm props
   arm_id: # needs to be arm_record_id?
     Desc: A unique identifier via which study arms can be differentiated from one another across studies/trials. <br>This property is used as the key via which child records, e.g. cohort records, or in some instances individual cases, can be associated with the appropriate study arm during data loading, and to identify the correct records during data updates.
@@ -2082,7 +2093,7 @@ PropDefinitions:
     Desc: A sequence of characters used to uniquely identify, name, or characterize the presence and nature of a consent group in a study.
     Term:
       - Origin: caDSR
-        Code: 'TBD'
+        Code: '16306756'
         Value: Study Consent Group Identifier
         Version: '1'
         Tags:
diff --git a/model-desc/icdc-model.yml b/model-desc/icdc-model.yml
index 1e508a4..30e6162 100644
--- a/model-desc/icdc-model.yml
+++ b/model-desc/icdc-model.yml
@@ -37,6 +37,7 @@ Nodes:
       - dates_of_conduct
       - accession_id
       - study_disposition
+      - study_accession
       - crdc_id
   consent_group:
     Desc: The Consent Group node contains properties required to characterize the consent groups defined within each study/trial. Consent groups are used to define subsets of patients/subjects/donors within a given study/trial, based upon the specific consents that those patients/subjects/donors provided at the time of enrollment.